Additionally, to comprehensively characterize the impact of TREM1 deficiency specifically within the tumor myeloid populations, we selectively enriched the CD45+CD11b+ tumor–infiltrating myeloid cells from tumor-bearing Trem1+/+ and Trem1–/– mice for scRNA-Seq analysis. This evidence concerns the gene ITGAM and neoplasm.